JYSB2000693 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2022-01-20 | view |
JYSB2000692 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2022-01-20 | view |
JYSB2000691 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2022-01-20 | view |
JYSB2000694 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2022-01-20 | view |
JYSB2000690 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2022-01-20 | view |
JYSB2000689 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2022-01-20 | view |
JYSB2000688 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2022-01-20 | view |
JYSB2000695 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2021-01-01 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2022-01-20 | view |
JXSS2000015 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Import Drug Application | 2020-05-23 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2021-03-30 | view |
JXSS2000014 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Import Drug Application | 2020-05-23 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2021-03-30 | view |
JXSS2000013 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Import Drug Application | 2020-05-23 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2021-03-30 | view |
JXSS2000012 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Import Drug Application | 2020-05-23 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | In Review | 2021-03-30 | view |
JYSB2000414 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-09-02 | view |
JYSB2000413 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-09-02 | view |
JYSB2000412 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-09-02 | view |
JYSB2000411 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2020-08-21 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | Filed | 2020-09-02 | view |
JYSB2000080 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2020-03-25 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2020-06-10 | view |
JYSB2000083 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2020-03-25 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2020-06-10 | view |
JYSB2000082 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2020-03-25 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2020-06-10 | view |
JYSB2000081 | 艾美赛珠单抗注射液 | emicizumab | Injection | Biological Products | Supplementary Application | 2020-03-25 | 罗氏(中国)投资有限公司 | Roche (China) Holding Ltd | Certificate Issued | 2020-06-10 | view |